Netherlands vs Switzerland: Cases started on MDR-TB treatment
Netherlands
13
in 2024
Switzerland
12
in 2024
Netherlands rank
113th
Switzerland rank
116th
Cases started on MDR-TB treatment over time
- Netherlands
- Switzerland
How they compare
Netherlands currently reports 13 against 12 in Switzerland, a difference of 1.
That makes Netherlands's figure about 1.1 times Switzerland's.
The two have swapped places 4 times across 13 shared years of data; in 2010 it was Netherlands ahead.
Netherlands ranks 113th and Switzerland ranks 116th of 193 countries.
Netherlands has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Netherlands | Switzerland | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 11.5 | 9.5 | 2 | Netherlands |
| 2020s | 8.2 | 6.4 | 1.8 | Netherlands |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher cases started on mdr-tb treatment, Netherlands or Switzerland?
- Netherlands, at 13 against 12 in Switzerland as of 2024.
- What is the difference in cases started on mdr-tb treatment between Netherlands and Switzerland?
- 1, with Netherlands ahead.
- How many years of comparable data are there for Netherlands and Switzerland?
- 13 years are reported by both, from 2010 to 2024.
- How do Netherlands and Switzerland rank globally for cases started on mdr-tb treatment?
- Netherlands ranks 113th and Switzerland ranks 116th of 193 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Cases started on MDR-TB treatment. Statizoid refreshes it automatically from the source and publishes the full history for both places.